Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.35 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.35 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17616828 | 0.90 | MAPK1 (0.39) | CYP3A4TP53KDM4ETDP1MAPK1 | |
| SCHEMBL11338767 | 0.87 | KDM4E (0.40) | CYP3A4TP53KDM4ETDP1MAPK1 | |
| SCHEMBL472150 | 0.85 | KDM4E (0.42) | CYP3A4TP53KDM4ETDP1MAPK1 | |
| SCHEMBL17616840 | 0.83 | MAPK1 (0.39) | KDM4ETDP1MAPK1KMT2AMEN1 | |
| SCHEMBL29753313 | 0.81 | MAPK1 (0.37) | CYP3A4TP53KDM4ETDP1MAPK1 | |
| SCHEMBL472104 | 0.81 | MIF (0.40) | KDM4ETDP1MAPK1KMT2AMEN1 | |
| SCHEMBL17601883 | 0.80 | MAPK1 (0.42) | KDM4ETDP1MAPK1KMT2AMEN1 | |
| SCHEMBL17616839 | 0.80 | MAPK1 (0.42) | KDM4ETDP1MAPK1KMT2AMEN1 | |
| SCHEMBL17838081 | 0.79 | MAPK1 (0.41) | KDM4ETDP1MAPK1KMT2AMEN1 | |
| SCHEMBL27853809 | 0.78 | MAPK1 (0.35) | KDM4ETDP1MAPK1SMN1; SMN2CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9499505-B2 | Process for the epoxidation of olefins | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-11-22 | — | — | US | disclosed |
| US-9499505-B2 | Process for the epoxidation of olefins | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-11-22 | — | — | US | disclosed |
| US-20160177023-A1 | CONTINUOUS PROCESS OF OLEFINIC EPOXIDATION BY SUPPORTED HETEROPOLY ACID | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-06-23 | — | — | US | disclosed |
| US-20160177023-A1 | CONTINUOUS PROCESS OF OLEFINIC EPOXIDATION BY SUPPORTED HETEROPOLY ACID | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-06-23 | — | — | US | disclosed |
| US-20160083360-A1 | PROCESS FOR THE EPOXIDATION OF OLEFINS | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-03-24 | — | — | US | disclosed |
| US-20160083360-A1 | PROCESS FOR THE EPOXIDATION OF OLEFINS | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083360-A1 | PROCESS FOR THE EPOXIDATION OF OLEFINS | HSF1, HMOX1, HSPH1 | CYP3A4 236/4885TP53 2328/4885KDM4E 4503/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.